US2019091282A1PendingUtilityA1
Peptides for use in promoting transport of glucose
Est. expiryJul 16, 2035(~9 yrs left)· nominal 20-yr term from priority
C07K 14/415A61K 9/14A23V 2002/00A61K 38/10A61P 3/10A61K 38/08A61K 8/9789A61K 8/9794A23L 33/18C07K 7/08C07K 7/06A61K 38/00A61P 21/00A61P 5/50A61K 38/168A23L 2/38
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A natural glucose transport promoting peptide comprising a glucose transport promoting fragment of a protein selected from SEQUENCE ID NO's: 1 to 6, and a composition comprising a plurality of glucose transport promoting peptides, is described. Also disclosed is the use of the peptides and compositions in improving muscle status in a mammal, especially promoting recovery of muscle following exercise or enhancing physical performance.
Claims
exact text as granted — not AI-modified1 . A comestible powder comprising a peptide having 8-50 amino acids and comprising a fragment of a protein of SEQUENCE ID NO: 1 selected from the group consisting of: SEQUENCE ID NO's 7 to 20, 181, 190-195, 204, 207 and 216-218.
2 . A comestible powder according to claim 1 in which the fragment is selected from the group consisting of: SEQUENCE ID NO: 7 or 13.
3 .- 40 . (canceled)
41 . A comestible powder according to claim 1 , including all of the peptides of SEQUENCE ID NO's 7 to 20.
42 . A comestible powder according to claim 1 , in which the comestible powder is a nutritional supplement or a food additive.
43 . A method of improving glycaemic management in a mammal comprising a step of orally administering to the mammal a comestible powder of claim 1 , in which glycaemic management in the mammal is improved by one or more of lowering plasma blood glucose levels, treating or preventing hyperglycaemia, increasing post prandial insulin secretion, regulating glucose homeostasis, and reducing or attenuating insulin resistance.
45 . A method according to claim 43 , in which glycaemic management in the mammal is improved by lowering plasma blood glucose levels.
46 . A method according to claim 43 , in which the mammal is a human with pre-diabetes or diabetes.Join the waitlist — get patent alerts
Track US2019091282A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.